Aquinox to Present at the 16th Annual Needham Healthcare

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
52
Aquinox to Present at the 16th Annual Needham Healthcare Conference

VANCOUVER, British Columbia, March 29, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, announced today that David Main, President & CEO, will provide a corporate update at the upcoming 16th Annual Needham Healthcare Conference in New York on Wednesday, April 5 th 2017 .

Aquinox Presentation Details:

Date: Wednesday, April 5 th 2017 Time: 1:40 pm Eastern Time / 10:40 am Pacific Time  Location: New York, NY – Westin New York Grand Central

A live audio webcast and archive of the event will be available at:

http://wsw.com/webcast/needham80/aqxp

To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled start time. An archived version of the webcast will also be available on the Investor Relations page of the Aquinox website. The corporate overview being presented will be available following the presentation at www.aqxpharma.com .

About Aquinox Pharmaceuticals, Inc.

Aquinox Pharmaceuticals, Inc. is a late clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. Our primary focus is anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1, or SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. Aquinox's lead drug candidate, AQX-1125, is a small molecule activator of SHIP1 suitable for oral, once daily dosing.  In September 2016, we began enrolling patients in a Phase 3 clinical trial of AQX-1125 in our lead indication, Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).  Other indications are under consideration for future investigation. Aquinox has a broad intellectual property portfolio and pipeline of preclinical drug candidates that activate SHIP1. For more information, please visit www.aqxpharma.com .

Investor Contact Info:

Brendan Payne  Associate Director, Investor Relations  Aquinox Pharmaceuticals, Inc. 604.901.3019 ir@aqxpharma.com

Gitanjali Ogawa  Vice President  The Trout Group 
 646-378-2949
 Gogawa@troutgroup.com  

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fermi's Leadership Saga: Proxy Wars and Power Struggles

Updated Category News Views 97

Unfolding the Drama at Fermi (NASDAQ:FRMI) You'd think you were watching a suspense drama unfold, not an annual shareholder meeting report. The co-founder of Fermi, Toby Neugebauer, stepped into the spotlight, throwing shade at Rick Perry and the board's shaky status quo. Pitting Shareholders Against the Board Neugebauer isn't mincing words about the current state of...

Continue Reading
SM Investments Wins Five Golden Arrows: Governance on Point

Updated Category News Views 106

Gold Arrows and Golden Standards What’s in a bunch of gold arrows, you might ask? Well, for SM Investments Corporation, those Five Golden Arrows from the Institute of Corporate Directors aren't just shiny trinkets. They're badges of honor, symbols of a rock-solid governance fortress. For the third year running, they’ve nailed the top spot under the corporate...

Continue Reading
212NYC Gala Celebrates Ad Industry's Human Touch

Updated Category News Views 81

The Advertising Gala with Heart When you toss nearly 300 advertising honchos into a room at Tribeca's Rooftop, you don't just get another bash; you get an industry checkpoint. This time, the 212NYC shindig on November 5, 2026, wasn't just about stroking egos. It was about spotlighting the soul in business, right when AI threatens to run wild with it. Navigating AI's...

Continue Reading
Pepsi Drivers in Georgia Gear Up for a Strike Showdown

Updated Category News Views 79

Teamsters Turn Up the Heat in Georgia Well, folks, buckle up because we've got ourselves a brewing labor storm down in Georgia! Over 100 Pepsi-Cola drivers, holding the steering wheel firm under Teamsters Local 528, are about ready to slam their fists down and go on strike. They've had it up to here with management's tap-dancing around negotiations. Drivers Say Enough Is...

Continue Reading
IRTC Faces Investigation: Shares Plunge Amid Uncertainty

Updated Category News Views 23

Securities Trouble on the Horizon: IRTC Takes a Hit Wake up and adjust your seat, folks—iRhythm Technologies (NASDAQ:IRTC) is in the spotlight, and it ain't pretty. Shares nosedived over 30% in a single morning, stirring up quite the murky waters for shareholders. The trigger? A less-than-stellar third-quarter report. The Numbers Don't Lie—Or Do They? Management...

Continue Reading
Havertys Dividend: A Steady Payout Tradition Continues

Updated Category News Views 76

Another Year, Another Dividend for Havertys Man, talk about a company with a rock-solid habit. Havertys Furniture Companies (NYSE: HVT) just announced its latest cash dividend, cementing a tradition that's been rolling since 1935. They're dropping $0.33 per share on the common stock and $0.31 on the Class A common stock. It's set to hit investors' pockets by December 9,...

Continue Reading
Lilly's Digital Healthcare Push with Hims & Hers

Updated Category News Views 89

Revolutionizing Access: Pharmaceuticals Meet Telehealth In an era where digital disruption is shaking every sector, Eli Lilly (NYSE:LLY) isn't sitting idle. They've just forged a partnership with Hims & Hers (NYSE:HIMS), one that's diving headfirst into the telehealth revolution. We're talking a slick merger of pharmaceuticals and digital platforms—offering FDA-approved...

Continue Reading
QORAI CORP's Q4 Nexus: A New AI Frontier

Updated Category News Views 51

Breakthrough in AI: Enter Q4 Nexus It's not every day you see a tech player emerge with something genuinely fresh—QORAI CORP is shaking up the scene with its Q4 Nexus platform. This isn't just another AI model upgrade. We're talking about a rethink of the very architecture we rely on to power these systems. Founder Robby Joshi's brainchild, Q4 Nexus, jazzes up the AI...

Continue Reading
Teneo Expands Financial Advisory in Canada, Eyes Talent

Updated Category News Views 59

Turning the Maple Leaf Over: Teneo's Move Alright, here's the scoop: Teneo is muscling its way north, into Canada, to flex its Financial Advisory chops. With a lineup of 60 professionals already setting the pace across Toronto, Montreal, and Calgary, this move isn’t just smoke—it’s a full-fledged expansion. They're under the hood, tinkering away to beef up...

Continue Reading
Lululemon Faces Class Action Amid Sales Decline

Updated Category News Views 123

Looks like Lululemon Athletica Inc. (NASDAQ: LULU) is in the hot seat, and not in the cozy yoga session kind of way. Investors are gearing up for a legal face-off thanks to a class action lawsuit alleging some serious corporate sleight of hand. What Triggered This Legal Storm? Turns out, between March 18 and September 3, 2026, things didn't go as planned for Lululemon....

Continue Reading

Top 5 Most Recently Viewed Articles

Inside Patrick Industries: Key Stock Movement and Future Prospects

Updated Category News Views 94

Recent Insider Transactions at Patrick Industries In a notable move, Todd M. Cleveland, a director at Patrick Industries Inc. (NASDAQ:PATK), recently sold stock worth over $1.3 million. This transaction has drawn the attention of investors, shedding light on the company's performance and the management's confidence. Details of the Transaction The sale took place over two...

Continue Reading
ISS Endorses Titan Medical's Merger with Conavi for Growth

Updated Category News Views 111

Titan Medical Gains Support for Amalgamation with Conavi Titan Medical Inc. (TSX: TMD; OTC: TMDIF) is excited to announce that the independent proxy advisory firm, Institutional Shareholder Services (ISS), has recommended shareholders support the proposed amalgamation with Conavi Medical Inc. This endorsement is particularly important as Titan’s shareholders prepare for...

Continue Reading
Rising Credit Card Fraud in Canada: Key Insights for Safety

Updated Category News Views 344

Understanding the Rise of Credit Card Fraud In recent times, credit card fraud has become a pressing issue, particularly in Canada. The latest findings from Equifax Canada’s Market Pulse Fraud Trends and Insights Report shed considerable light on this concerning trend. As we delve into the statistics and expert opinions, it becomes evident that this problem is not...

Continue Reading
Geronimo Power Launches Bee Hollow Solar Project in Illinois

Updated Category News Views 231

Geronimo Power Begins Construction of Bee Hollow Solar Project Geronimo Power has embarked on an exciting new venture, breaking ground on its 150-megawatt (MW) Bee Hollow Solar project. This project, strategically located in Illinois, aims to generate a tremendous economic impact. The local economy stands to gain $54 million over the entirety of the project due to new tax...

Continue Reading
Examining Bit Digital Trends: The Rise in Options Activity

Updated Category News Views 161

Understanding Recent Options Activity of Bit Digital Financial institutions are taking noticeable bearish stances on Bit Digital. A thorough examination of the options history for Bit Digital (NASDAQ: BTBT) reveals a total of 25 unusual trades, warranting a closer look into their implications. Trends in Trader Sentiment Upon delving into trader behaviors, our analysis...

Continue Reading